Lifecore Biomedical Sees FY2026 Sales $74.000M-$76.000M vs $127.802M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $74.000 million-$76.000 million vs $127.802 million analyst estimate.
Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $74.000 million-$76.000 million vs $127.802 million analyst estimate.